Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
State-of-the-art on aortic regurgitation; the French experience of TAVI for PAVR...

NEW ISSUE

Sep 2
State-of-the-art on aortic regurgitation; the French experience of TAVI for PAVR...

OFDI vs IVUS guidance in PCI for ACS; PCI and acute ischaemic stroke; coronary artery innervation; vasomotion results from the BIOMAG-I study; debating the use of microaxial flow pumps for CS; and more

State-of-the-Art

Sep 2
AR: from mechanisms to management
Andreas Baumbach, Alexander R. Tamm, et al.

The article provides an overview of the epidemiology, assessment, treatment options, and unmet needs for aortic regurgitation, highlighting the role of advanced imaging, the evolution of surgical and transcatheter therapies, and the need for further research on dedicated transcatheter devices for pure aortic regurgitation.

AR: from mechanisms to management

Original Research

Sep 2
French experience of TAVI for PAVR
Robin Le Ruz, Vincent Letocart, et al.

In this article, transcatheter aortic valve implantation with new-generation devices for pure aortic valve regurgitation is shown to be reasonably safe, but patients remain at high risk of mortality, heart failure hospitalization, and valve reintervention long-term.

French experience of TAVI for PAVR

CORE CURRICULUM

Aug 30
EAPCI Core Curriculum
Rui Campante Teles, Dariusz Dudek, et al.
The document outlines the Core Curriculum for training interventional cardiologists in structural, valvular, and non-valvular heart disease interventions, describing the required knowledge, skills, and attitudes.
EAPCI Core Curriculum
free

ORIGINAL RESEARCH

Aug 26
Off-hours effects in STEMI-CS treated with MCS
Takahiro Suzuki, Atsushi Mizuno, et al.
In a Japanese registry of STEMI-CS patients treated with Impella, off-hours admissions were associated with a higher 30-day mortality risk compared to on-hours admissions.
Off-hours effects in STEMI-CS treated with MCS

ORIGINAL RESEARCH

Aug 26
New AF in ACS patients
Willem Lambertus (Wilbert) Bor, Jurrien M. ten Berg, et al.
Newly diagnosed atrial fibrillation in acute coronary syndrome patients was associated with higher rates of major adverse cardiovascular events and ischemic stroke compared to those without or with known atrial fibrillation, despite lower rates of oral anticoagulant prescription.
New AF in ACS patients

Aug 23
EuroIntervention at ESC 2024

The EuroIntervention team and Editors will be at ESC 2024. Several hotlines, guidelines, and late-breaking sessions will be released during ESC 2024 in London. Prepare for the congress by reading or re-reading EuroIntervention's relevant articles.

EuroIntervention at ESC 2024
Receive our newsletter


Subscribe banner

STATE-OF-THE-ART

Aug 20
Antithrombotic therapy for transcatheter structural heart intervention
This review discusses the device-related thrombotic risk and antithrombotic management for various transcatheter structural heart interventions, highlighting the need for tailored approaches to balance safety and efficacy.
Antithrombotic therapy for transcatheter structural heart intervention
free

EDITORIAL

Aug 13
OCT guidance in STEMI patients
Francesco Prati, Laura Gatto

This paper presents an innovative proof-of-concept study on the use of OCT-guided coronary interventions in acute coronary syndrome, and concludes that further randomized studies are needed to confirm this approach.

free

RESEARCH CORRESPONDENCE

Aug 13
First-in-human self-expanding coronary sinus reducer
Julio I. Farjat-Pasos, Jean-Michel Paradis, et al.
This first-in-human study demonstrates the periprocedural safety and feasibility of the A-Flux coronary sinus reducer, a new transcatheter device for the treatment of refractory angina, with no complications and good short-term clinical results.
First-in-human self-expanding coronary sinus reducer

ORIGINAL RESEARCH

Aug 8
Morphofunctional assessment in ACS patients
Yuto Osumi, Hiromasa Otake, et al.
This retrospective study found that combining morphological (OCT-detected TCFA) and physiological (low post-PCI QFR, high ΔQFRNCS) assessments can identify ACS patients at high risk of subsequent target vessel failure after PCI.
Morphofunctional assessment in ACS patients
free

EDITORIAL

Aug 8
Morphofunctional assessment post-PCI in ACS
Shengxian Tu, Jelmer Westra

This article discusses the ongoing debate around the use of wire-based physiology versus imaging to guide revascularization in acute coronary syndrome, and suggests that improvements in imaging techniques may lead to better patient outcomes in the future.


free

DEBATE

Aug 8
Is bivalirudin ready for a comeback?
Gregg W. Stone, Rod H. Stables, et al.
The study compares the use of bivalirudin and heparin as anticoagulation agents in patients with acute coronary syndromes undergoing percutaneous coronary intervention, with mixed results on outcomes such as mortality, stent thrombosis, and bleeding.
Is bivalirudin ready for a comeback?
free

Trending articles
202.9

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
160.58

State-of-the-Art

10.4244/EIJ-D-22-00725 Jan 23, 2023
Mitral valve transcatheter edge-to-edge repair
Hausleiter J et al
free
75.75

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
58.35

Clinical research

10.4244/EIJ-D-20-00975 May 16, 2021
Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial
de Belder A et al
free
58.05

Clinical research

10.4244/EIJ-D-22-01125 Jul 17, 2023
Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy
Grubb KJ et al
free
47.3

Clinical research

10.4244/EIJ-D-22-01030 Jun 5, 2023
Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves
Wienemann H et al
free

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved